BE PSY MED
ActiveBE PSY MED has been active since 2021 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €231k and a net result of €83k. Equity is growing by ~52.3% per year across the filed fiscal years. Its solvency ranks better than 73% of 19907 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
Checked score
Score 2024
97
/ 100
Excellent
The score weighs solvency, liquidity, profitability and financial development. Bankruptcy probability contributes 35%. Every signal that weighs is under Signals.
Axes · tick = 2023
Profitability100=
Solvency100▲+4
Growth78▲+26
Track record94
Bankruptcy probability, 12 months
0.2%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €22k at 30 days acceptable
Liquidity ample (current ratio 13.8 against 7.54 in 2023; short-term debt: 6.2% and cash: 81.2% of total assets), and 16% of the assets are financed with debt.
Credit advice for your own amount and term
Signals
Six signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Sector 86
lower
← fewer bankruptcies
more bankruptcies →
raises risk · Limited track record
This company has not been active as long as an established one and statistically fails somewhat more often.
KBO · incorporation dateAge against the risk zone
lowers risk · Annual accounts: healthy financial profile
The latest annual accounts show a healthy profile in solvency, result and liquidity.
NBB · annual accounts 2024Solvency, return and age of the figures
Solvency
84%
Return on assets
30.2%
Age of the figures
21 mo
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 27-06-2025, 34 days ahead of the deadline.
NBB · 3 filingsDeviation from the deadline
2025
not confirmed
2024
34 d early
2023
41 d early
2022
26 d early
← before the deadline
after the deadline →
Financials · fiscal year 2024, micro schema
Equity
€231k▲ 56.2%
2023 · €148k
2022: €76k
2023: €148k
2022 → 2024
Total assets
€274k▲ 31.8%
2023 · €208k
2022: €149k
2023: €208k
2022 → 2024
Net result
€83k▲ 16.3%
2023 · €71k
2022: €74k
2023: €71k
2022 → 2024
Working capital
€218k▲ 60.2%
2023 · €136k
2022: €65k
2023: €136k
2022 → 2024
Multi-year overview
Every figure with its change against the year before
▲ rise
▼ fall
Line202220232024Trend
Equity€76k-€148k▲ 93.5%€231k▲ 56.2%
Operating result€93k-€92k▼ 1.4%€101k▲ 10.2%
Net result€74k-€71k▼ 4.0%€83k▲ 16.3%
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 10% above 2023 and is the highest result in the available series.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €274k
Fixed assets
€39k▼ 23.2%
Current assets
€235k▲ 49.8%
Equity and liabilities €274k
Equity
€231k▲ 56.2%
Debt
€44k▼ 27.5%
The debt ratio falls from 29.1% to 16.0%. Equity is higher and debt is lower.
Key figures and ratios
EBITDA
€114k▲
2023 · €105k
Cash flow
€96k▲
2023 · €84k
Solvency
84.0%▲
2023 · 70.9%
Current ratio
13.80▲
2023 · 7.54
Quick ratio
13.80▲
2023 · 7.54
Debt / equity
0.19▼
2023 · 0.41
ROE
36.0%▼
2023 · 48.3%
ROA
30.2%▼
2023 · 34.3%
Interest coverage
70.78▲
2023 · 52.75
Debt
€44k▼
2023 · €61k
Debt ≤ 1 year
€17k▼
2023 · €21k
Debt > 1 year
€27k▼
2023 · €40k
Income taxes
€17k▼
2023 · €19k
Green means a favourable move, even when the figure itself falls: as with debt or debt / equity.
Filed annual accounts
As filed with the NBB · 2024 against 2023
Balance sheet
Code20232024
Assets
Total assets20/58€208k€274k▲
Fixed assets21/28€51k€39k▼
Tangible fixed assets22/27€51k€39k▼
Plant, machinery and equipment23€0-
Furniture and vehicles24€51k€39k▼
Financial fixed assets28€195€195=
Current assets29/58€157k€235k▲
Amounts receivable within one year40/41€4k€5k▲
Other amounts receivable41€4k€5k▲
Cash at bank and in hand54/58€147k€223k▲
Deferred charges and accrued income490/1€6k€7k▲
Equity and liabilities
Total equity and liabilities10/49€208k€274k▲
Equity10/15€148k€231k▲
Contributions10/11€2k€2k=
Profit (loss) carried forward14€146k€229k▲
Amounts payable17/49€61k€44k▼
Amounts payable after more than one year17€40k€27k▼
Financial debts170/4€40k€27k▼
Amounts payable within one year42/48€21k€17k▼
Current portion of amounts payable after more than one year42€12k€13k▲
Trade debts44€1k€2k▲
Suppliers440/4€1k€2k▲
Taxes, remuneration and social security45€7k€3k▼
Taxes450/3€5k-
Remuneration and social security454/9€3k€3k=
Income statement
Code20232024
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€13k€13k▲
Other operating charges640/8€6k€1k▼
Gross operating margin9900€111k€116k▲
Operating profit (loss)9901€92k€101k▲
Financial income75/76B€21€6▼
Recurring financial income75€21€6▼
Financial charges65/66B€2k€2k▼
Recurring financial charges65€2k€2k▼
Profit (loss) for the period before taxes9903€90k€100k▲
Income taxes67/77€19k€17k▼
Profit (loss) for the period9904€71k€83k▲
Profit (loss) for the period to be appropriated9905€71k€83k▲
Appropriation of the result
Profit (loss) to be appropriated9906€146k€229k▲
Profit (loss) brought forward from the previous period14P€74k€146k▲
The notes to these accounts (7 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.
Timeline · acts, filings and financial milestones
2025
27-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Highest result since 2022net €83k ▲16.3%
Operating result €101k, net result €83k, both a record.
31-12
Financial
Equity above €200kEq €231k ▲56.2%
3 profitable years in a row build equity to €231k.
20-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
31-12
Financial
Weakest financial yearnet €71k ▼4%
Net result drops to €71k, the lowest in the series; recovery starts the following year.
31-12
Financial
Equity above €100kEq €148k ▲93.5%
2 profitable years in a row build equity to €148k.
05-07
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Colfontaine · 1 establishment unit since 2021
Cannot be placed on the map
This address could not be matched to a point in the Belgian address register (BOSA BEST). The address below comes straight from the Crossroads Bank.
Rue du Tour 32 F7340 ColfontaineGround area
1.2 ha
Building footprint
1,042 m²
Volume, LiDAR
11,836 m³
2 parcels, Wallonia · tallest building 15.1 m, ±4 floors. Linked by address, not a title deed.
1 establishment unit
BE PSY MED
since 20212.327.271.807
2 parcels
Wallonia
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 53053D0031/00M004 | Wallonia | 1.2 ha | 1 · 986 m² | 15.1 m · 4 fl. |
| 53079A0016/00Z000 | Wallonia | 152 m² | 1 · 56 m² | 7.7 m · 2 fl. |
Linked by address, not proof of ownership
Methodology
via registered seat: 1 · via establishment units: 1
2 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Similar companies · same sector, comparable size
JYP.Med.Society
BE 1003.856.265
Anthisnes · Eq €231k
DOKTER ALAIN MAHJOUB
BE 0477.947.506
Beveren-Kruibeke-Zwijndrecht · Eq €231k
Dr. Tom (Thomas) van Cann
BE 0792.600.163
Aartselaar · Eq €231k
BELGIAN MEDICAL ONCOLOGY CONSULTANCY
BE 0791.233.453
Etterbeek · Eq €231k
Psylise
BE 0779.907.120
Brugge · Eq €231k
Of 16,628 companies in sector 86220 we hold annual accounts for 7,973. 6,662 are within a factor 10 of this equity.See the whole sector
Company data · Crossroads Bank
Identification
Legal formPrivate limited company
Founded26-11-2021
Fiscal year end31-12
Activities, NACEBEL
86220Specialist medical practice
86904Human health activities
86931Psychology services
Sources
Crossroads Bank for EnterprisesNational Bank · 3 filingsAddress and cadastre registers
Data from official sources, last processed on 21-09-2026. Scores and ratios are computed by Checked and are not a credit decision.